Лучшие больницы для «ASD Closure Surgery» в Дубай, ОАЭ

The cost of ASD Closure Surgery varies based on the technique used and the hospital chosen. In India, at leading JCI and NABH-accredited cardiac hospitals (such as those in Chennai, Mumbai, Hyderabad, or New Delhi), the all-inclusive cost for transcatheter device closure typically ranges from USD 3,500 to USD 5,500, while minimally invasive or open surgical repair ranges from USD 5,000 to USD 7,000. These packages generally include the procedure, the implant device (e.g., Amplatzer Septal Occluder), hospital stay, ICU care, standard medications, and pre-discharge echocardiography. In the UAE, at JCI and DHA-accredited hospitals in Dubai and Abu Dhabi, the equivalent costs range from USD 8,000 to USD 12,000 for transcatheter closure and USD 11,000 to USD 16,000 for surgical repair. UAE packages typically include a higher nurse-to-patient ratio, premium private room accommodation, and access to multi-disciplinary international teams. India is generally 40–60% more cost-effective than the UAE for this procedure, while both destinations deliver outcomes — device success rates, complication rates, and long-term closure durability — that are fully comparable to North American and European centers. GAF Healthcare provides a transparent, itemized cost estimate for your specific case before any commitment is made, with no hidden charges.

The required in-country stay before it is safe to board an international flight depends primarily on the closure technique used. For transcatheter device closure: Most patients are clinically ready for short-haul international travel approximately 10–14 days after the procedure. Before flight clearance is given, the treating cardiologist will perform a follow-up transthoracic echocardiogram (typically at Day 7–10 post-procedure) to confirm stable device position, rule out pericardial effusion, and verify absence of a significant residual shunt. A chest X-ray is also reviewed. For long-haul flights (exceeding 6–8 hours), a minimum of 2 full weeks of recovery in-country is strongly recommended. Most centers recommend compression stockings and ambulatory movement during the flight to mitigate DVT risk, as patients are on antiplatelet therapy during the endothelialization phase. For minimally invasive surgical or open surgical repair: A minimum in-country stay of 3–4 weeks is required before international air travel is considered safe. Cardiopulmonary bypass and thoracic surgery increase the risk of pleural effusion and pneumothorax, both of which must be excluded by chest X-ray before the patient is cleared for a pressurized cabin environment. Wound healing (thoracotomy or sternotomy), normalization of inflammatory markers (CRP, WBC), and stable cardiac function on echocardiography are all prerequisites. The operating surgeon and cardiologist jointly issue the fitness-to-fly certificate. GAF Healthcare factors the full in-country recovery period into the initial travel plan and accommodation arrangements, ensuring the patient is never rushed to travel before clinical clearance is given.

ASD Closure Surgery carries one of the highest success rates of any cardiac intervention. At experienced, high-volume centers in India and the UAE — the tier of hospitals partnered with GAF Healthcare — the technical procedural success rate (complete or near-complete defect closure confirmed on intraoperative or immediate post-procedure echocardiography) exceeds 98–99%. For transcatheter device closure specifically: Complete closure (no residual shunt on echocardiography) is achieved in approximately 95% of patients at 24-hour post-procedure assessment and rises to over 98% at 12-month follow-up as the nitinol device endothelializes and minor peri-device traces seal. Device embolization requiring retrieval occurs in fewer than 0.5% of cases. The rare but serious complication of cardiac erosion (device perforating the aortic root or atrial wall) has an incidence of approximately 0.1% and is managed by careful patient selection — particularly avoiding oversized devices in patients with absent aortic rim — at experienced centers. For surgical repair: Operative mortality for isolated ASD closure in expert pediatric cardiac surgery programs is less than 0.5%. Patch repair provides immediate, durable anatomical closure with no device-related long-term concerns. Patients who undergo successful ASD closure before the age of 25 — and particularly in childhood — demonstrate normalization of right ventricular dimensions, resolution of pulmonary artery pressures, and a life expectancy comparable to the general population. Adults closed after age 40 have somewhat attenuated right heart reverse remodeling, though most still experience significant symptomatic improvement and reduced risk of progressive pulmonary hypertension and atrial arrhythmias. Long-term surveillance is nevertheless recommended: annual echocardiography for at least 3–5 years, with particular attention to device integrity, atrial arrhythmia burden, and residual pulmonary pressures in patients who had pre-operative hypertension. GAF Healthcare facilitates remote follow-up coordination so that long-term monitoring continues seamlessly with your home-country cardiologist.